COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONISTS VERSUS WARFARIN IN ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND DIABETES

被引：0
|
作者：
Korgaonkar, S. [1 ]
Yang, Y. [2 ]
Banahan, B., III [3 ]
Bentley, J. P. [2 ]
机构：
[1] Univ Mississippi, Dept Pharm Adm, Oxford, MS USA
[2] Univ Mississippi, University, MS 38677 USA
[3] Univ Mississippi, Ctr Pharmaceut Mkt & Management, University, MS 38677 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.448
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV12
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [31] Risk versus Benefit of Non-Vitamin K Dependent Anticoagulants Compared to Warfarin for the Management of Atrial Fibrillation in the Elderly
    Kelechi C. Ogbonna
    Sean M. Jeffery
    Drugs & Aging, 2013, 30 : 513 - 525
  • [32] EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol
    Luo, Xuemei
    Li, Xiaoyan
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan, Xianying
    Di Fusco, Manuela
    Garcia, Alessandra Bassalobre
    Yuce, Huseyin
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 434 - 434
  • [33] Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Sogaard, Mette
    Kjaeldgaard, Jette Nordstrom
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    STROKE, 2019, 50 (04) : 939 - 946
  • [34] Effectiveness and safety of non-vitamin K oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke: A systematic review and meta-analysis
    Shi, Minglei
    Liu, Lu
    Wafa, Hatem
    Curcin, Vasa
    Wang, Yanzhong
    NEUROEPIDEMIOLOGY, 2024, 58 (01) : 1 - 14
  • [35] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients With Non-Valvular Atrial Fibrillation and Diabetes
    Deitelzweig, Steve
    Keshishian, Allison
    Li Xiaoyan
    Dhamane, Amol
    Luo Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan Xianying
    Nadkarni, Anagha
    Di Fusco, Manuela
    Garcia, Alessandra B.
    Yuce, Huseyin
    Lip, Gregory Y.
    CIRCULATION, 2018, 138
  • [36] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
    Cha, Myung-Jin
    Choi, Eue-Keun
    Han, Kyung-Do
    Lee, So-Ryoung
    Lim, Woo-Hyun
    Oh, Seil
    Lip, Gregory Y. H.
    STROKE, 2017, 48 (11) : 3040 - +
  • [37] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [38] Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Peripheral Artery Disease
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    STROKE, 2018, 49
  • [39] Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
    Mark J. Alberts
    Jinghua He
    Akshay Kharat
    Veronica Ashton
    American Journal of Cardiovascular Drugs, 2022, 22 : 425 - 436
  • [40] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
12345